sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> pediatric vaccines market

report

Pediatric Vaccines Market, by Disease Type (Hepatitis A, Hepatitis B, Measles, Mumps, Diphtheria, Polio, Meningococcal, Tetanus, Varicella, Pneumococcal Disease, Haemophilias Influenza Type B), Vaccine Type (Inactive Vaccines, Attenuated Vaccines, Toxoids, Conjugates, Recombinant Vector Vaccines) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC183 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the pediatric vaccines market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the pediatric vaccines market. The scope of this report covers the pediatric vaccines market by its major segments, which include the types of diseases, types of vaccines, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The growing government and non-government subsidizing for the development of the antibodies is one of the significant drivers for the pediatric vaccines market.
  • On the other hand, technological advancements will further boost the global pediatric vaccines market.
  • The vaccination plans given to the children and the awareness programs promoted u the organizations such as UNICEF, WHO, and other social welfare organizations are additionally driving the growth of the pediatric antibody market.
  • However, the increasing expenses of antibodies, low availability to remote territories and stringent regulations for the approvals of the vaccines are some of the components affecting the worldwide pediatric vaccines market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s pediatric vaccines market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the pediatric vaccines market by the following segments:

  • Pediatric Vaccines Market, by Disease Type
    • Diphtheria
    • Haemophilus Influenzae Type B
    • Hepatitis A
    • Hepatitis B
    • Measles
    • Meningococcal
    • Mumps
    • Pneumococcal Disease
    • Polio
    • Tetanus
    • Varicella
  • Pediatric Vaccines Market, by Vaccine Types
    • Attenuated Vaccines
    • Conjugates
    • Inactive Vaccines
    • Recombinant Vector Vaccines
    • Toxoids

KEY MARKET PLAYERS

Key players in the pediatric vaccines market include:

  • Pfizer Inc.
  • Merck & Company
  • GlaxoSmithKline PLC
  • Novartis AG
  • Baxter International
  • Emergent Bio Solution
  • Sanofi
  • MedImmune, LLC
  • Bavarian Nordic
  • Bharat Biotech
  • AlphaVax

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Pediatric Vaccines Market

TRENDING RELATED REPORT

Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
    4. Assumption
    5. Limitation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. PEDIATRIC VACCINES MARKET, BY DISEASE TYPES
    1. Segment Share
    2. Disease Types
      1. Diphtheria
      2. Haemophilus Influenzae Type B
      3. Hepatitis A
      4. Hepatitis B
      5. Measles
      6. Meningococcal
      7. Mumps
      8. Pneumococcal Disease
      9. Polio
      10. Tetanus
      11. Varicella
  6. PEDIATRIC VACCINES MARKET, BY VACCINE TYPES
    1. Segment Share
    2. Vaccine Types
      1. Attenuated Vaccines
      2. Conjugates
      3. Inactive Vaccines
      4. Recombinant Vector Vaccines
      5. Toxoids
  7. PEDIATRIC VACCINES MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Disease Types
      3. By Vaccine Types
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Disease Types
      3. By Vaccine Types
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Disease Types
      3. By Vaccine Types
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Disease Types
      3. By Vaccine Types
  8. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players
  9. KEY MARKET PLAYERS
    1. Baxter International, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. AlphaVax
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Bavarian Nordic
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Baxter International
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Bharat Biotech
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Emergent Bio Solution
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. GlaxoSmithKline plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. MedImmune, LLC
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Merck & Co.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    11. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    12. Sanofi S.A.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us